Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL321439 | 0.89 | CA2 (0.58) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL474830 | 0.87 | CA2 (0.56) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL1581836 | 0.86 | CA2 (0.54) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL14893547 | 0.86 | CA2 (0.54) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL29013953 | 0.84 | CA2 (0.46) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL28127359 | 0.83 | CA2 (0.68) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL5695531 | 0.82 | CA2 (0.49) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL332766 | 0.82 | CA2 (0.61) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL29435138 | 0.81 | CA2 (0.66) | CA2CA1MAPK1ATML3MBTL1 | |
| SCHEMBL8058023 | 0.80 | CA2 (0.44) | CA2CA1MAPK1ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2547528-B1 | LIQUID DROPLET EJECTING METHOD, LIQUID DROPLET EJECTION APPARATUS, INKJET RECORDING APPARATUS, PRODUCTION METHOD OF FINE PARTICLES, FINE PARTICLE PRODUCTION APPARATUS, AND TONER | RICOH CO LTD (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-107209466-B | Toner, toner-containing unit, and image-forming apparatus | 株式会社理光 | 2020-09-22 | — | — | CN | disclosed |
| US-10712681-B2 | Toner, toner storage unit, image forming apparatus, and method for manufacturing toner | RICOH COMPANY, LTD. (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20190235405-A1 | TONER, TONER STORAGE UNIT, IMAGE FORMING APPARATUS, AND METHOD FOR MANUFACTURING TONER | RICOH COMPANY, LTD. (JP) | 2019-08-01 | — | — | US | disclosed |
| EP-3260918-B1 | TONER, TONER-HOUSING UNIT, AND IMAGE-FORMING APPARATUS | RICOH CO LTD (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-10151991-B2 | Toner, toner stored unit, and image forming apparatus | RICOH COMPANY, LTD. (JP) | 2018-12-11 | — | — | US | disclosed |
| EP-2296058-B1 | Image forming apparatus | RICOH CO LTD (JP) | 2018-08-01 | — | — | EP | disclosed |
| EP-2746350-B1 | COATING COMPOSITION FOR CHROMIUM THIN FILM COATING | FUJIKURA KASEI KK (JP) | 2018-02-28 | — | — | EP | disclosed |
| EP-3260918-A1 | TONER, TONER-HOUSING UNIT, AND IMAGE-FORMING APPARATUS | Ricoh Company, Ltd. (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20170343912-A1 | TONER, TONER STORED UNIT, AND IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2017-11-30 | — | — | US | disclosed |
| EP-1703332-A2 | Method for producing a toner, and toner | Ricoh Company, Ltd. (JP) | 2006-09-20 | — | — | EP | disclosed |
| US-7094512-B2 | Electrophotographic printing method, monoazo iron complex compound, charge controlling agent using the same and toner using the charge controlling agent | HODOGAYA CHEMICAL CO., LTD. (JP) | 2006-08-22 | — | — | US | disclosed |
| EP-1609782-A1 | MONOAZO IRON COMPLEX COMPOUND, CHARGE CONTROL AGENT CONTAINING THE SAME, AND TONER | Hodogaya Chemical Co., Ltd. (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6897000-B2 | Charge controlling agent, method for producing the same and toner for developing electrostatic image | HODOGAYA CHEMICAL CO., LTD. (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20040191660-A1 | Electrophotographic printing method, monoazo iron complex compound, charge controlling agent using the same and toner using the charge controlling agent | HODOGAYA CHEMICAL CO., LTD. (JP) | 2004-09-30 | — | — | US | disclosed |
| US-6627368-B2 | Retains charge instantly, maintains charge density | HODAGAYA CHEMICAL CO., LTD. (JP) | 2003-09-30 | — | — | US | disclosed |
| US-20030162111-A1 | Charge controlling agent, method for producing the same and toner for developing eletrostatic image | HODOGAYA CHEMICAL CO., LTD. (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1332408-A2 | CHARGE CONTROLLING AGENT, METHOD FOR PRODUCING THE SAME AND TONER FOR DEVELOPING ELECTROSTATIC IMAGE | Hodogaya Chemical Co., Ltd. (JP) | 2003-08-06 | — | — | EP | disclosed |
| WO-2002037188-A2 | CHARGE CONTROLLING AGENT, METHOD FOR PRODUCING THE SAME AND TONER FOR DEVELOPING ELECTROSTATIC IMAGE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2002-05-10 | — | — | WO | disclosed |
| US-20010004667-A1 | Organic metal complex compound and electrostatic image developing toner using the same | HODOGAYA CHEMICAL CO.,LTD. (JP) | 2001-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162111-A1 | Charge controlling agent, method for producing the same and toner for developing eletrostatic image | CA2, HCAR2, CALCOCO2 | CA2 1/4885CA1 8/4885MAPK1 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.